menu
    • menu

    Company profile for Moberg Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Moberg Pharma North America LLC (formally Alterna LLC) is the owner and marketer of therapeutic, over-the-counter (OTC) medicines and health and beauty aid (HBA) brands. Since 2004, our mission has been to provide unique over the counter healthcare products to consumers and establish strong brands that increase profit for retailers. As a mid-market company we offer unique strengths in our ability to devote attention and resou...
    Moberg Pharma North America LLC (formally Alterna LLC) is the owner and marketer of therapeutic, over-the-counter (OTC) medicines and health and beauty aid (HBA) brands. Since 2004, our mission has been to provide unique over the counter healthcare products to consumers and establish strong brands that increase profit for retailers. As a mid-market company we offer unique strengths in our ability to devote attention and resources to niche brands and categories. Moberg Pharma North America LLC principal brands, Kerasal®, Kerasal Nail® and JointFlex®.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Moberg PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7 East Frederick Place
    Telephone
    Telephone
    (973) 946-7550
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.mobergpharma.com/contact
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Karo Healthcare Secures Exclusive License For MOB-015 In Europe
    Karo Healthcare Secures Exclusive License For MOB-015 In Europe

    06 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/moberg-pharma-and-karo-healthcare-enter-into-an-exclusive-license-agreement-for-mob-015terclara-in-europe-expanding-access-and-growth-potential-302605296.html

    PR NEWSWIRE
    06 Nov 2025
    Share Share
    Moberg Pharma's Nomination Committee Appointed
    Moberg Pharma's Nomination Committee Appointed

    31 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-31/moberg-pharma-s-nomination-committee-appointed

    PHARMIWEB
    31 Oct 2025
    Share Share
    Moberg Pharma Expands Board, Withdraws Share Issue Authorization
    Moberg Pharma Expands Board, Withdraws Share Issue Authorization

    04 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-04/moberg-pharma-to-expand-board-of-directors-and-withdraw-share-issue-authorization

    PHARMAWEB
    04 Sep 2025
    Share Share
    Terclara (MOB-015) is now being launched in Norway
    Terclara (MOB-015) is now being launched in Norway

    03 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/terclara-mob-015-is-now-being-launched-in-norway-302366261.html

    PR NEWSWIRE
    03 Feb 2025
    Share Share
    New terbinafine supplier secured
    New terbinafine supplier secured

    18 Dec 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-12-18/new-terbinafine-supplier-secured

    PHARMAWEB
    18 Dec 2024
    Share Share
    Moberg Reports Phase 3 Data, Regains EU Rights To MOB-015
    Moberg Reports Phase 3 Data, Regains EU Rights To MOB-015

    10 Dec 2024

    // PRESS RELEASE

    https://news.cision.com/moberg-pharma/r/moberg-pharma-reports-topline-data-in-the-north-american-phase-3-study-and-will-regain-rights-to-mob,c4080496

    PRESS RELEASE
    10 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search